Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07115017) titled 'This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis' on Aug. 4.
Study Type: Observational
Primary Sponsor: Washington University School of Medicine
Condition:
Multiple Sclerosis
Intervention:
Drug: [18F] FZTA
Recruitment Status: Recruiting
Date of First Enrollment: August 2025
Target Sample Size: 80
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07115017
Pub...